BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29893484)

  • 1. Clinical utility of endocrine markers predicting myocardial siderosis in transfusion dependent thalassemia major.
    Ehsan L; Rashid M; Alvi N; Awais K; Nadeem O; Asghar A; Sajjad F; Fatima M; Qidwai A; Hussain S; Hasan E; Brown N; Altaf S; Hasan B; Kirmani S
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27285. PubMed ID: 29893484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine complications in patients with Thalassaemia Major.
    Toumba M; Sergis A; Kanaris C; Skordis N
    Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients.
    El Beshlawy A; El Tagui M; Hamdy M; El Ghamrawy M; Azim KA; Salem D; Said F; Samir A; St Pierre T; Pennell DJ
    Ann Hematol; 2014 Mar; 93(3):375-9. PubMed ID: 23949317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
    Casale M; Citarella S; Filosa A; De Michele E; Palmieri F; Ragozzino A; Amendola G; Pugliese U; Tartaglione I; Della Rocca F; Cinque P; Nobili B; Perrotta S
    Am J Hematol; 2014 Dec; 89(12):1102-6. PubMed ID: 25197009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of iron overload complications among patients with b-thalassemia major treated at Dubai Thalassemia Centre.
    Belhoul KM; Bakir ML; Kadhim AM; Dewedar HE; Eldin MS; Alkhaja FA
    Ann Saudi Med; 2013; 33(1):18-21. PubMed ID: 23458935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
    Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
    Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.
    Tanner MA; Galanello R; Dessi C; Westwood MA; Smith GC; Nair SV; Anderson LJ; Walker JM; Pennell DJ
    J Cardiovasc Magn Reson; 2006; 8(3):543-7. PubMed ID: 16755844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
    Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
    Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study.
    Casale M; Meloni A; Filosa A; Cuccia L; Caruso V; Palazzi G; Gamberini MR; Pitrolo L; Putti MC; D'Ascola DG; Casini T; Quarta A; Maggio A; Neri MG; Positano V; Salvatori C; Toia P; Valeri G; Midiri M; Pepe A
    Circ Cardiovasc Imaging; 2015 Aug; 8(8):e003230. PubMed ID: 26253625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population.
    Di Odoardo LAF; Giuditta M; Cassinerio E; Roghi A; Pedrotti P; Vicenzi M; Sciumbata VM; Cappellini MD; Pierini A
    Intern Emerg Med; 2017 Sep; 12(6):799-809. PubMed ID: 28456904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years.
    Poggi M; Sorrentino F; Pugliese P; Smacchia MP; Daniele C; Equitani F; Terlizzi F; Guitarrini MR; Monti S; Maffei L; Losardo A; Pasin M; Toscano V
    Ann Hematol; 2016 Apr; 95(5):757-63. PubMed ID: 26957357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major.
    Kosaryan M; Rahimi M; Darvishi-Khezri H; Gholizadeh N; Akbarzadeh R; Aliasgharian A
    Hemoglobin; 2017 May; 41(3):151-156. PubMed ID: 28762844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major.
    Westwood MA; Wonke B; Maceira AM; Prescott E; Walker JM; Porter JB; Pennell DJ
    J Magn Reson Imaging; 2005 Aug; 22(2):229-33. PubMed ID: 16028255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain natriuretic peptide as marker of myocardial iron load in beta-thalassemia.
    Nikolidakis S; Flessa C; Nikolaou N; Gotsis ED; Koutouzis M; Polyhronaki E; Vrettou E; Kyriakides ZS
    Int J Cardiol; 2007 Jun; 118(3):408-9. PubMed ID: 17045671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.
    Leonardi B; Margossian R; Colan SD; Powell AJ
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):572-8. PubMed ID: 19356483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR; De Sanctis V; Gilli G
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac complications and iron overload in beta thalassemia major patients-a systematic review and meta-analysis.
    Koohi F; Kazemi T; Miri-Moghaddam E
    Ann Hematol; 2019 Jun; 98(6):1323-1331. PubMed ID: 30729283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate variability in β-thalassaemia major with or without cardiac siderosis.
    Alp A; Ozdogan O; Guloglu CC; Turker M; Atabay B
    Cardiol Young; 2014 Apr; 24(2):263-7. PubMed ID: 23402458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation Between Cardiac T2* Values and Electrocardiographic Parameters in Children With Transfusion-dependent Thalassemia.
    Aggarwal P; Kumar I; Jain A; Verma A; Gupta V
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e610-e614. PubMed ID: 32032245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.